相关实验视频

Updated: May 3, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

生命细胞:首次获得批准

¹Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. mdt@adis.com.

Molecular diagnosis & therapy

|April 16, 2024

概括

一种新的瘤透性淋巴细胞 (TIL) 细胞疗法Lifileucel已经获得了针对晚期黑色素瘤的加速批准. 这种开创性的治疗方法为那些没有对先前疗法的反应的患者提供了新的选择.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

Lifileucel是一种来自瘤透淋巴细胞 (TIL) 的自主T细胞疗法.
它是由Iovance生物疗法公司开发的,用于癌症治疗.
Lifileucel针对的是无法切除或转移性黑色素瘤的患者.

研究的目的:

总结 lifileucel 的发展里程碑.
为了突出其在美国的首次加速批准.
详细说明其在先前治疗过晚期黑色素瘤患者中的有效性.

主要方法:

Lifileucel是由患者自己的瘤透淋巴细胞 (TIL) 衍生和扩展的.
该疗法涉及一次性管理.
批准是基于客观响应率 (ORR).

主要成果:

在美国,Lifileucel在2024年2月获得加速批准.
适用于患有不可切除或转移性黑色素瘤的成年患者.
该患者群体包括之前接受过PD-1阻断抗体和BRAF抑制剂治疗的患者,如适用.

结论:

Lifileucel代表了黑色素瘤治疗的重大进展.
该疗法为耐火性晚期黑色素瘤提供了一个新的选择.
这次批准标志着基于TIL的细胞疗法的一个里程碑.

更多相关视频

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

FDA Approved Drugs: Changes to Approved Drugs

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...